Study of an Expandable Interbody Device for the Lumbar Spine
- Conditions
- Degenerative Disc Disease
- Interventions
- Device: CALIBER
- Registration Number
- NCT02075554
- Lead Sponsor
- Globus Medical Inc
- Brief Summary
The primary objective of this study is to evaluate the safety and efficacy of CALIBER expandable spacer for the treatment of degenerative disc disease. Radiographic outcomes, intra-operative parameters, clinical outcomes, and patient satisfaction will be obtained from patients in this 2 year follow-up clinical study.
- Detailed Description
Patients will be followed-up at 3weeks, 6 weeks, 3 months, 6 months, 12 and 24 months with X-rays and questionnaires to determine their satisfaction, healing, fusion and return to work status
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 58
- DDD at 1 or 2 levels between L2 and S1
- Between 18 and 80 years of age
- Unresponsiveness to documented non-surgical treatment modalities for a minimum of six months
- Ability to provide a signed Informed Consent
- Trauma at level(s) to be fused
- Previous documentation of osteopenia, osteoporosis, or osteomalacia to a degree that spinal instrumentation would be contraindicated
- Immunosuppressive disorder
- History of substance abuse
- Any known allergy to a metal alloy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description CALIBER CALIBER 1 or 2 levels of DDD between L2 and S1, treated with transforaminal interbody fusion
- Primary Outcome Measures
Name Time Method Fusion and Disc Height Maintenance 24 months Inter-vertebral disc height in millimetres at 24 month follow up.
Fusion Assessment 24 months An assessment of the fusion status of surgically treated spinal levels.
- Secondary Outcome Measures
Name Time Method Patient Self Assessment Upto 24 mo Oswestry Disability Index. A 10 item questionnaire with responses scored 0 to 5 and then presented as a percentage score from 0 to 100, with higher scores denoting more disability.
Visual Analog Scale for Back Pain 24 months A visual scale from 0 to 100 in which the patient responds with their pain level by marking on the line, higher as more severe pain.
Trial Locations
- Locations (2)
Carolina NeuroSurgery and Spine Associates
🇺🇸Charlotte, North Carolina, United States
South Florida Spine Institute at Mt Sinai Medical Center
🇺🇸Miami Beach, Florida, United States